Human CYP2C19 Gene Polymorphism Detection Kit

A molecular diagnostics reagent kit for human CYP2C19 gene typing using PCR with fluorescent probes. The kit supports pharmacogenetic testing for personalized medicine applications.

A gene genotyping detection kit for human CYP2C19 gene analysis using PCR with fluorescent probe methodology. It supports pharmacogenetic testing for precision medicine applications. Available variants: Human CYP2C19 Gene Genotyping Detection Kit (PCR Fluorescent Probe Method).

Specialized gene detection kit for analyzing CYP2D6 genetic variations to predict drug metabolism and response. This test enables precision medicine by guiding drug selection and dosing for individual patients.

CE IVD real-time PCR kit for detection of CYP2C9 polymorphisms (*2A, *13, HapB3, c2846A>T) according to CPIC and DPWG guidelines. Enables personalized dosing of warfarin and other CYP2C9-metabolized medications.

In vitro diagnostic kit for detecting metabolic enzyme gene polymorphisms to assess individual drug metabolism capacity and guide personalized medication therapy. Uses molecular analysis to identify genetic variants affecting cytochrome P450 and other metabolic enzymes, enabling clinicians to optimize drug selection and dosing based on patient pharmacogenetic profiles.

In vitro diagnostic kit for detecting CYP2C9 and VKORC1 gene polymorphisms to guide warfarin dosing and reduce adverse drug reactions. Enables pharmacogenomic-based anticoagulation therapy optimization in patients requiring warfarin treatment.

In vitro diagnostic kit for detecting clopidogrel-resistance gene polymorphisms to guide antiplatelet therapy decisions. Uses molecular analysis to identify genetic variants affecting clopidogrel metabolism in patients at risk of thrombotic events. Enables personalized treatment selection and dosing optimization for improved clinical outcomes.

Genetic testing kit for analyzing drug metabolism genes and predicting medication response. Supports personalized medicine and optimized drug dosing based on genetic profiles.

A genotyping kit for CYP2C19 genetic analysis. It is designed for use with the advanced fragment analysis applications platform.

Molecular diagnostic kit for identifying genetic variations affecting drug metabolism in cardiovascular disease patients. Provides guidance for personalized medication selection in heart disease management.

Single nucleotide polymorphism detection kit for pharmacogenomics and disease predisposition analysis. Provides reliable genotyping across large sample populations.

Molecular diagnostic kit for genetic testing and variant detection. Supports precision medicine applications in cardiovascular and oncology disease management.